Capstone Therapeutics (CAPS) Announces Adjournment of Its Annual Meeting of Stockholders and Intention to Reconvene the Meeting on June 28, 2011
6/8/2011 10:54:31 AM
TEMPE, Ariz., June 8, 2011 (GLOBE NEWSWIRE) -- Capstone Therapeutics (Nasdaq:CAPS) (the "Company") announced that at its Annual Meeting held on Monday June 6, 2011, there were insufficient shares represented by person or by proxy at the meeting to establish a quorum for the election of directors. Accordingly, the meeting was adjourned and scheduled to reconvene on June 28, 2011 at 10:00 AM PDT at the Company's offices located at 1275 W. Washington Street, Suite 101, Tempe, Arizona.
comments powered by